Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/agm2.12140 http://scihub22266oqcxt.onion/10.1002/agm2.12140 33738381!7954841!33738381     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Aging+Med+(Milton) 2021 ; 4 (1): 53-57 Nephropedia Template TP {{tp|p=33738381|t=2021. Progress in the risk assessment of hydroxychloroquine in frail elderly people |pdf=|usr=}}{{33738381}} gab.com Text Progress in the risk assessment of hydroxychloroquine in frail elderly people JO: Aging Med (Milton) http://www.kidney.de/pget.php?&tw=1&pmid=33738381 #FOAvip Hydroxychloroquine (HCQ) is an antimalarial drug also known to have anti-inflammatory and antiviral effects. The antiviral action of HCQ has been a point of interest for many researchers because of its mechanism of action and the potential use it could have during the current COVID-19 pandemic. However, HCQ can cause QT interval prolongation. The current therapies used in COVID-19 are changing as the pandemic develops. The aim of this article is to promote a validated risk score for QT prolongation in multidimensional assessment of COVID-19 patients, especially in elderly and polypathological patients. Twit Text FOAVip Progress in the risk assessment of hydroxychloroquine in frail elderly people ????Aging Med (Milton) http://www.kidney.de/pget.php?&tw=1&pmid=33738381 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33738381 #FOAvip English Wikipedia <ref>{{Cite pmid|33738381}}</ref> Progress in the risk assessment of hydroxychloroquine in frail elderly people #MMPMID33738381 Castagna A; Ruotolo G; Manzo C Aging Med (Milton) 2021[Mar]; 4 (1): 53-57 PMID33738381show ga Hydroxychloroquine (HCQ) is an antimalarial drug also known to have anti-inflammatory and antiviral effects. The antiviral action of HCQ has been a point of interest for many researchers because of its mechanism of action and the potential use it could have during the current COVID-19 pandemic. However, HCQ can cause QT interval prolongation. The current therapies used in COVID-19 are changing as the pandemic develops. The aim of this article is to promote a validated risk score for QT prolongation in multidimensional assessment of COVID-19 patients, especially in elderly and polypathological patients. äProgress in the risk assessment of hydroxychloroquine in frail elderly(epmc).pdf DeepDyve Pubget Overpricing